Carib Scope

分类： health

  • SLBMC Welcomes ABCAS Interns Across Multiple Departments

    SLBMC Welcomes ABCAS Interns Across Multiple Departments

    A new cohort of aspiring healthcare workers has begun their professional training at Antigua and Barbuda’s Sir Lester Bird Medical Centre (SLBMC), through a collaborative internship initiative with the Antigua and Barbuda College of Advanced Studies (ABCAS). Hospital leaders have framed the program as a strategic investment in the future of local healthcare, designed to bridge the gap between academic learning and on-the-job clinical practice.

    Unlike traditional classroom-based education, the internship offers students unmatched hands-on experience in a real hospital setting, while also letting them make tangible contributions to patient care and daily hospital operations. In an official announcement shared by the medical center, representatives noted that this program marks the start of a transformative journey for the young trainees, one where academic knowledge directly translates to meaningful impact for patients and the broader healthcare system.

    Oversight of the internship will be handled entirely by SLBMC’s in-house Learning and Development Unit, which will organize structured mentorship, personalized guidance, and regular professional development sessions throughout the full duration of the traineeship. Hospital officials emphasized that the core mission of the partnership extends far beyond simple workplace exposure: it is intentionally crafted to equip emerging professionals with the practical skills, clinical confidence, and professional networks they need to build long-term careers in healthcare, while building a pipeline of skilled talent for the island nation’s healthcare sector long into the future.

  • Saint Lucia gets tool to detect outbreaks faster

    Saint Lucia gets tool to detect outbreaks faster

    Ten Caribbean countries and territories have successfully upgraded their diagnostic capabilities with cutting-edge Molbio rapid PCR testing platforms, a development that is set to revolutionize how the region detects and responds to infectious disease outbreaks. The rollout, completed by March 26 under the Pandemic Fund Project, is led by the Caribbean Public Health Agency (CARPHA), which confirmed Saint Lucia, Barbados, The Bahamas, Belize, Dominica, Grenada, Guyana, Jamaica, the Turks and Caicos Islands, and Trinidad and Tobago as the participating member states.

    Unlike traditional testing setups that can take multiple days to deliver results, the new platform delivers accurate diagnostic outputs for a wide range of pathogens in under two hours. The technology is designed to detect more than a dozen high-priority infectious diseases that pose major threats to public health in the region, including SARS-CoV-2, influenza, cholera, malaria, HIV, hepatitis, tuberculosis, salmonella, leptospirosis and rabies. It also has the capacity to test for pathogens with high pandemic potential, such as Nipah virus and norovirus, filling a critical gap in the region’s early warning systems.

    Following the completion of installations, the initiative is moving into its next operational phase: routine diagnostic testing across all participating sites. All testing data will be compiled and shared on a weekly basis with CARPHA through the platform’s integrated digital reporting system, enabling seamless aggregation of information into regional public health surveillance networks. This connected data infrastructure allows for continuous monitoring of platform performance and supports coordinated, fast-acting responses when new disease threats emerge.

    Complementing the hardware rollout, CARPHA has also completed targeted training for more than 50 laboratory professionals across the participating countries, building sustainable local technical capacity to operate and maintain the new systems. This hands-on training ensures that national health networks can leverage the full potential of the technology long after the initial deployment.

    CARPHA Executive Director Dr. Lisa Indar framed the successful completion of installations as a transformative milestone for regional public health infrastructure. “By combining cutting-edge diagnostic technology with targeted workforce training, CARPHA is ensuring that countries are better prepared to detect, respond to and manage public health threats in real time,” she said.

    The initiative has already demonstrated its value in emergency response scenarios. During Hurricane Melissa that impacted Jamaica in October 2025, the platform was installed and local staff were fully trained within just a few days, enabling immediate emergency testing and boosting the country’s disaster response readiness. Looking ahead, the upgraded diagnostic systems are expected to cut turnaround times for diagnosis from days to under two hours, enabling earlier case identification, faster isolation of infected individuals, and more effective containment of outbreaks. This progress ultimately strengthens regional surveillance capabilities and boosts the long-term resilience of national health systems across the Caribbean.

  • PAHO announces regional agreement to secure pandemic influenza vaccines for Latin America and the Caribbean

    PAHO announces regional agreement to secure pandemic influenza vaccines for Latin America and the Caribbean

    Against the backdrop of ongoing global circulation of high-risk zoonotic viruses such as avian influenza, the Pan American Health Organization (PAHO) has launched a landmark public-private partnership with Australian pharmaceutical firm CSL Seqirus to strengthen pandemic preparedness across Latin America and the Caribbean, ensuring more equitable and timely access to pandemic influenza vaccines when the next public health emergency strikes.

    At the core of the new agreement is a pre-negotiated dose allocation mechanism that earmarks a fixed portion of CSL Seqirus’ global pandemic influenza vaccine production exclusively for participating PAHO member states. If a pandemic is declared, participating nations will immediately gain access to an initial pre-reserved pool of doses, eliminating the chaotic bidding wars and supply shortages that left many regions scrambling for vaccines during the height of the COVID-19 pandemic. This framework is built directly on hard-won lessons from the global COVID-19 crisis, which exposed deep gaps in regional preparedness and global vaccine equity, particularly for middle-income countries.

    To add resilience to the regional supply chain, partial vaccine manufacturing will take place locally in Argentina in collaboration with domestic biotech firm Sinergium Biotech. This arrangement not only brings production closer to end users but also supports long-term growth of regional biomanufacturing capacity, a key priority identified in post-COVID-19 public health reforms. CSL Seqirus will lead global development of pandemic influenza vaccines and support technology transfer to regional partners, drawing on the company’s decades of specialized expertise in influenza research and large-scale vaccine production.

    PAHO Director Jarbas Barbosa emphasized that the agreement marks a transformative shift for regional health security. “This agreement is a direct response to the hard lessons of COVID-19 and a major step forward in strengthening health security and pandemic preparedness across the Americas,” Barbosa said. “Through our Regional Revolving Funds, countries are joining forces to secure a reserved share of vaccine production, helping protect those at risk when it matters most.”

    Barbosa added that for the first time, countries across the Americas are approaching future pandemic response as a unified bloc rather than fragmented individual markets, putting the region on far more equal footing with wealthy nations that typically outcompete lower and middle-income countries for limited global vaccine supplies. By pooling collective demand through PAHO’s Regional Revolving Funds, participating countries can negotiate better terms and ensure access even when global demand surges.

    David Ross, Executive Vice President and General Manager at CSL Seqirus, called the partnership a model for proactive pandemic preparedness. “This agreement puts pandemic preparedness best practices into action, bringing together reserved doses, regional manufacturing capability, and a long-term public-private commitment,” Ross said. “We’re proud to establish this kind of partnership in Latin America and the Caribbean for the first time.”

    Alejandro Gil, President and CEO of Sinergium Biotech, noted that the deal builds on more than a decade of collaboration between his firm, PAHO, and CSL Seqirus. Fifteen years of investment in infrastructure and workforce development have now positioned Sinergium to deliver high-quality vaccines to the region, aligning with PAHO’s regional public health strategies. “For Sinergium, it is a source of pride to be able to contribute in such a significant way to public health in the region,” Gil said.

    The agreement, which followed a full year of negotiations and an international competitive procurement process, addresses a longstanding structural gap that has disadvantaged middle-income countries during global health crises. These nations often lack the purchasing power to secure early vaccine access from manufacturers, but are also excluded from the emergency support programs offered to the world’s poorest countries.

    When a pandemic does occur, dose allocation from the reserved pool will be guided by real-time epidemiological data and formal risk assessments, with high-priority access guaranteed to the most vulnerable populations. PAHO officials stressed that this framework shifts the region from a reactive crisis response model to a proactive, pre-planned system that can cut through supply chain delays and global competition to deliver doses when they are needed most.

    Public health experts have repeatedly identified animal-borne influenza viruses as one of the highest-risk pathogens for triggering the next global pandemic, making proactive preparedness for a pandemic influenza event a top global health priority. PAHO officials noted that this new agreement sets a precedent for regional cooperation that could be replicated in other parts of the world to improve global pandemic preparedness overall.

  • Health authorities monitoring hantavirus outbreak; no local cases reported

    Health authorities monitoring hantavirus outbreak; no local cases reported

    A global public health monitoring effort is underway after a hantavirus outbreak emerged aboard the cruise vessel MV Hondurus, with the Caribbean nation of Saint Lucia confirming it remains at low risk of local transmission as authorities track the evolving situation.

    The cruise ship set sail from Argentina on April 1, carrying a diverse group of passengers and crew representing 28 nationalities. As of May 11, the outbreak has been linked to nine reported hantavirus infections, three of which have resulted in fatalities. Five of the nine cases have received formal laboratory confirmation, and public health investigators are continuing active surveillance to detect unreported cases and curb further spread of the pathogen.

    In an official public statement released Tuesday, Dr. Michelle Francois, Saint Lucia’s leading national epidemiologist, reaffirmed the island’s current risk status. “At present, Saint Lucia is considered to be at low risk for hantavirus transmission…. At this time, there are no suspected or confirmed cases of virus in Saint Lucia,” she stated.

    Francois explained that all nations with citizens who disembarked from the infected vessel are coordinating closely with global public health agencies to conduct ongoing monitoring of all exposed passengers and crew for early signs of infection. Health authorities have also received notification that one Caribbean national onboard the ship may have been exposed to the virus, but the government of that country has since confirmed no suspected or confirmed infections have been detected within its borders to date.

    Per the epidemiologist, the World Health Organization (WHO) has also assessed the global public health risk posed by the outbreak as low, though officials note that additional cases may still surface in coming weeks due to hantavirus’s lengthy incubation period.

    For context, hantavirus is primarily a zoonotic pathogen, meaning it most often spreads to humans from direct contact with infected rodents, specifically through exposure to the animals’ urine, feces, or saliva. Limited person-to-person transmission has only ever been recorded for the Andes virus strain – the same strain connected to this current outbreak – and even this route of infection requires close, prolonged contact with an already infected individual to occur.

    Common early symptoms of hantavirus infection include fever, persistent headache, muscle pain, abdominal discomfort, nausea, and vomiting. In the most severe cases, the infection can progress rapidly to dangerous respiratory complications, including persistent coughing, shortness of breath, dangerous fluid accumulation in the lungs, and even septic shock.

    To support public prevention efforts, Saint Lucia’s Ministry of Health, Wellness and Nutrition has issued updated guidance for residents. People traveling to regions affected by the outbreak are advised to avoid areas known to have high rodent populations whenever possible. For anyone cleaning spaces that have been contaminated by rodents, the Ministry strongly recommends using appropriate personal protective equipment, including disposable face masks and rubber gloves, as well as effective disinfectants to reduce the risk of exposure to airborne virus particles.

    Saint Lucia’s health department says it will continue to monitor all developments related to the MV Hondurus outbreak closely, and will issue timely public updates as new information becomes available.

  • SLBMC Medical Director Pays Tribute to Nurses on International Nurses Day

    SLBMC Medical Director Pays Tribute to Nurses on International Nurses Day

    Every year on May 12, the global healthcare community pauses to mark International Nurses Day, a moment dedicated to honoring the outsized contributions that nursing professionals make to public health and patient wellbeing around the world. This year, Dr. Shivon Belle Jarvis, Medical Director of Antigua and Barbuda’s Sir Lester Bird Medical Centre, used the annual observance as an opportunity to deliver a heartfelt message of appreciation to her facility’s nursing staff, lauding their unshakable dedication to patient care and framing their work as foundational to the future of effective healthcare delivery.

    In her address, Dr. Jarvis emphasized that the global public health goal of “Health for All” is entirely unachievable without the consistent, frontline contributions of nursing teams. Unlike many public health initiatives that rely on high-level policy or cutting-edge technology, universal access to quality care stands or falls on the daily work of nurses, who are often the first point of contact for patients and the most consistent presence throughout a person’s care journey.

    Against this backdrop, Dr. Jarvis outlined clear institutional responsibilities to support the nursing workforce. She argued that fostering leadership pathways, funding and facilitating ongoing professional development, granting meaningful autonomy within frameworks of shared hospital governance, providing structured mentorship opportunities for early-career nurses, and prioritizing the mental health and wellness of nursing staff are not optional perks—they are core obligations that every healthcare institution must meet to retain and empower its teams.

    Beyond institutional commitments, Dr. Jarvis called for sustained, targeted public and private investment in the nursing profession globally. Adequate resourcing, she noted, is the only way to create an environment where nurses can grow their careers, avoid burnout, and continue delivering the high-standard care that patients depend on. She closed by reminding nursing staff that their core professional values—commitment to patients, camaraderie with colleagues, and empathetic care—are the guiding principles that will drive the entire healthcare sector toward a brighter, more equitable future. “You are Our Nurses, you are indeed our future, and lives will continue to be saved once you are empowered,” she told the facility’s team in her closing remarks.

  • Health Minister Completes Visits to Antigua’s Public Clinics for Nurses Week

    Health Minister Completes Visits to Antigua’s Public Clinics for Nurses Week

    As Nurses Week drew to a close across Antigua and Barbuda, the nation’s Minister of Health has completed a full circuit of public health clinics spread across the country, capping off a week of activities designed to honor the contributions of frontline nursing staff.

    The scheduled tour, planned intentionally to coincide with the annual recognition of nurses, gave the top health official a first-hand opportunity to engage directly with nursing teams at every public clinic, hear their on-the-ground challenges, recognize their daily efforts, and gain unfiltered insight into the operational needs of local primary care facilities.

    Throughout the week of visits, the minister met with nurses across rural and urban clinics, discussing a range of pressing topics from staffing shortages and equipment gaps to workplace support and ongoing professional development opportunities. Unlike formal pre-arranged inspection visits, this tour was structured around open dialogue, with many nurses sharing unvarnished feedback about the conditions they face while delivering care to local communities.

    In remarks following the completion of the tour, the health minister emphasized that nursing staff form the backbone of Antigua’s public health system, noting that their consistent, compassionate work is central to keeping communities healthy and ensuring the entire public health network functions effectively. The minister also reaffirmed the government’s commitment to addressing the key concerns raised during the visits, with a focus on improving working conditions, expanding training opportunities, and upgrading outdated infrastructure across public clinics in the coming months.

    The tour comes as Antigua’s health sector continues recovering from the lingering impacts of the COVID-19 pandemic, which placed unprecedented strain on frontline nursing workers across the nation. Health sector observers note that this high-profile engagement from the country’s top health official signals growing government recognition of the need to prioritize nursing workforce issues as part of broader public health system reform.

    Community health advocates have welcomed the move, saying that direct engagement between leadership and frontline staff is a critical first step toward resolving longstanding gaps in primary care delivery across Antigua. Many expect that the insights gathered during the tour will translate to tangible policy changes that benefit both nursing staff and the patients who rely on public clinic services every day.

  • Caribbean Countries to Get Priority Access to Pandemic Flu Vaccines

    Caribbean Countries to Get Priority Access to Pandemic Flu Vaccines

    Against a backdrop of persistent global zoonotic disease threats and hard-won lessons from the COVID-19 pandemic, the Pan American Health Organization (PAHO) has announced a groundbreaking public-private partnership with CSL Seqirus to reserve a dedicated supply of pandemic influenza vaccines for countries across Latin America and the Caribbean. This historic agreement creates a formal, pre-negotiated mechanism that locks in a fixed percentage of CSL Seqirus’ global pandemic influenza vaccine output for participating PAHO member states, guaranteeing eligible nations early access to an pre-allocated initial stock of doses when a public health emergency strikes.

    PAHO Director Dr. Jarbas Barbosa framed the agreement as a direct correction to gaps in global pandemic preparedness exposed by COVID-19, and a transformative leap forward for regional health security across the Americas. “Through our Regional Revolving Funds, countries are joining forces to secure a reserved share of vaccine production, helping protect those at risk when it matters most,” Barbosa explained. Leveraging CSL Seqirus’ decades of specialized experience in influenza research and large-scale vaccine manufacturing, the deal tasks the company with leading vaccine development and supporting targeted technology transfer to build regional capacity.

    A portion of vaccine production will be based at Argentina’s Sinergium Biotech, a partnership that directly addresses another critical lesson from the COVID-19 pandemic: the urgent need to strengthen local manufacturing capabilities and regional supply chain resilience. For CSL Seqirus, the partnership marks a first-of-its-kind commitment to pandemic preparedness in the region, bringing together pre-reserved doses, local production infrastructure, and long-term cross-sector collaboration. “We’re proud to establish this kind of partnership in Latin America and the Caribbean for the first time,” said David Ross, Executive Vice President and General Manager of CSL Seqirus.

    Alejandro Gil, President and CEO of Sinergium Biotech, noted that the collaboration builds on 15 years of capacity building and long-standing partnerships with both PAHO and CSL Seqirus. “The infrastructure and human resource capacities developed at Sinergium over the past 15 years now enable us to guarantee countries in the region access to quality products to respond to future pandemics, in line with the regional strategies defined by PAHO,” Gil said, adding that the work is a source of great pride for the firm.

    Negotiated over 12 months following an international competitive procurement process, the agreement is designed to cut down the timeline for securing life-saving vaccines during a pandemic, when global demand skyrockets and competition for limited supplies leaves many nations locked out. Critically, it is one of the first pre-pandemic supply arrangements specifically tailored to improve access for middle-income countries, which have long faced systemic disadvantages in competitive global vaccine markets.

    PAHO’s Regional Revolving Funds allow participating countries to pool their demand and negotiate as a unified bloc, putting Latin American and Caribbean nations on par with higher-income countries when it comes to securing favorable contract terms. This structure directly advances more equitable access to vaccines in a market that has historically favored wealthy nations. When a pandemic is declared, PAHO will allocate the reserved doses according to epidemiological data and public health risk, with top priority given to the region’s most vulnerable populations. By locking in supply in advance and establishing clear, pre-agreed allocation rules, the agreement shifts the region from a reactive, after-the-fact response model to a proactive, prepared approach.

    Barbosa emphasized that the deal marks an unprecedented shift for the region: “For the first time, countries of the Americas are positioning themselves on more equal footing in a future global health emergency—not as individual markets, but as a region. This agreement shows what is possible when we act together to leverage the power of pooled procurement.” As avian influenza and other emerging zoonotic threats continue to circulate globally, PAHO reiterated that sustained investment in pandemic preparedness remains an urgent public health priority. Virologists and global public health experts consistently identify influenza viruses, particularly those with zoonotic origins, as among the highest probability causes of the next global pandemic.

  • HPV Vaccine Rollout Sparks Renewed Church-State Clash in Schools

    HPV Vaccine Rollout Sparks Renewed Church-State Clash in Schools

    A decade after Belize first introduced the human papillomavirus (HPV) vaccine into its national public health portfolio, a long-simmering dispute between government health authorities and the country’s Catholic Diocese has reignited, putting life-saving immunization access for thousands of primary school girls at the center of a battle over institutional authority, religious values, and public health priorities.

    HPV, a widespread sexually transmitted infection, is conclusively linked to 70% of all cervical cancer cases as well as multiple other aggressive cancers. In 2016, Belize launched its national school-based HPV vaccination program targeting girls aged 9 to 13, a window recommended by the World Health Organization (WHO) to ensure protection before potential exposure to the virus. The initiative was a direct response to a grim public health reality: Belize has long recorded one of the highest cervical cancer mortality rates in Central America, a statistic public health officials have worked for a decade to reverse.

    Dr. Marvin Manzanero, Belize’s Director of Health Services, explained the program’s design in a 2016 briefing that remains relevant to the current rollout. “The WHO suggest that we should be vaccinating girls nine to thirteen years that is before they start to have sexual life. But we had to establish a cohort as we are introducing this and based on the attendance rate that we have from schools, which is where most of the girls of this age group are, the standard four classrooms are the ones being selected.” The current vaccine used in the program protects against strains 16 and 18 of HPV, the two high-risk variants responsible for the majority of cervical cancer diagnoses, Manzanero confirmed. Health officials note that meaningful reductions in cervical cancer mortality will take decades to emerge, as the disease develops slowly over 10 to 15 years after infection.

    This year’s scheduled nationwide immunization round has brought the long-running conflict back to the forefront. Citing longstanding policy established under former Bishop Dorick Wright, the Catholic Diocese has drawn a hard line against hosting the vaccine program in its schools. The Diocese oversees 110 of Belize’s 314 primary schools, meaning nearly 35% of the country’s primary school-aged girls could be blocked from accessing the free, school-based immunization offered through the national program.

    Not all Catholic-affiliated schools are aligning with the Diocesan directive, however. St. Martin De Porres RC School, a Jesuit institution operating outside Diocesan governance, is moving forward with its scheduled May 27 vaccination clinic for Standard Four students, aligning with the national public health schedule. The split reveals growing internal division within Belize’s Catholic community over how to balance institutional religious values with the health needs of students.

    Public health advocates have repeatedly emphasized the vaccine’s life-saving value. The Office of the Special Envoy for the Development of Families and Children issued a formal statement labeling HPV vaccination a critical intervention to protect children from HPV-related life-threatening diseases, including cervical cancer. Despite the public debate, however, none of the key stakeholders—including the Catholic Mission, Ministry of Health and Wellness, Ministry of Education, and Office of the Special Envoy for Women and Children—agreed to on-the-record interviews or clarification about the long-term impacts of the Diocese’s objection for affected students.

    As the scheduled rollout approaches, the stakes of the standoff have grown increasingly clear. Ten years into the program, public health officials anticipated steady progress toward expanding protection and reducing future cancer rates. Instead, access for thousands of eligible girls remains uncertain, with years of planned public health progress hanging in the balance. What was framed as a disagreement over institutional authority has ultimately placed the health of a generation of young Belizean women at the center of an unresolved church-state divide.

  • International Nurses Day 2026

    International Nurses Day 2026

    On May 12, nurses across the Caribbean island nation of Dominica joined healthcare workers around the globe in marking International Nurses Day 2025, anchored by this year’s official theme: “Our Nurses. Our Future. Empowered Nurses Save Lives.”

    As outlined in a recent analysis published by health platform medindia.net, the 2025 theme carries a deliberate, urgent message: sustained investment in supporting, protecting, respecting, and empowering nursing professionals is non-negotiable to strengthening global healthcare systems and improving patient outcomes worldwide.

    A core component of nursing empowerment, the analysis stresses, is prioritizing the physical and mental well-being of nurses themselves. Nursing is an inherently high-strain occupation: long shifting schedules, chronic emotional burnout from supporting vulnerable patients, extended periods of physical standing during procedures and rounds, and constant occupational exposure to infectious and severe illnesses all combine to put nurses’ health at persistent risk. Regular preventive health screenings and routine diagnostic blood work, the report notes, are critical tools that allow nurses to track their own health status, catch emerging concerns early, and access prompt care before conditions escalate.

    The modern observance of International Nurses Day traces its roots back more than half a century. The International Council of Nurses first formalized the global celebration in 1965, and in 1974, May 12 was permanently selected as the official date to honor the birth anniversary of Florence Nightingale, the foundational figure of modern nursing.

    Nightingale’s revolutionary work during the Crimean War redefined what nursing could be, shifting public perception from a marginalized trade to a respected professional field. By centering her practice on evidence-based patient care, strict clinical hygiene standards, and formal structured training for nursing staff, Nightingale laid the intellectual and operational groundwork for the modern nursing practices that underpin global healthcare today.

    Today’s International Nurses Day celebration honors the vast diversity of the nursing workforce, which serves across every corner of the health sector. From emergency and critical care units to maternity wards, community health clinics, pediatric practices, geriatric care facilities, preventive health programs, and mental health services, nurses work across every specialty to keep healthcare systems running. For most patients, nurses are the first and most frequent healthcare provider they interact with, making their work a direct determinant of patient comfort, treatment outcomes, trust in care, and overall safety.

    The scope of nursing work extends far beyond the clinical tasks outlined in job descriptions. On a day-to-day basis, nurses carry core responsibilities including tracking patient symptoms and vital signs, administering prescribed medications, supporting clinician treatment plans, assisting doctors during surgical and medical procedures, and educating patients on test protocols, medication management, post-treatment recovery, and therapeutic dietary adjustments. They also serve as critical emotional supports for patients and their families, providing clear, compassionate communication to reduce anxiety, help patients feel secure during illness and treatment, spot early warning signs of deteriorating health, and lead institutional and public education on infection control, hygiene, and preventive health habits.

    Beyond these technical duties, the analysis emphasizes that nursing is defined by its human core. Every day, nurses bring irreplaceable empathy, emotional resilience, sharp observational skills, and genuine compassion to patient care – qualities that no technological advancement can replicate, and that form the backbone of safe, effective healthcare.

    As Dominica joins the world in honoring the nursing workforce this International Nurses Day, the 2025 theme serves as a global reminder: empowered, supported nurses are not just a benefit to the profession – they are the foundation of a healthy, resilient future for communities everywhere.

  • Spain Confirms New Hantavirus Case as Cruise Ship Outbreak Grows to 11

    Spain Confirms New Hantavirus Case as Cruise Ship Outbreak Grows to 11

    On May 12, 2026, Spanish health authorities officially confirmed an additional case of hantavirus linked to the outbreak aboard the Dutch-operated expedition cruise vessel MV Hondius, pushing the total number of confirmed infections connected to the ship to 11, three of which have resulted in death.

    The newly confirmed patient is a Spanish citizen who had been placed under medical observation at Madrid’s Gómez Ulla Hospital. According to an official statement from Spain’s Ministry of Health, the patient recorded an initial preliminary positive result before the diagnosis was formally finalized on Tuesday. Contrary to earlier reports that indicated the patient’s symptoms were worsening, authorities confirmed that the individual is currently in stable condition. The ministry also added that 13 other passengers who were undergoing monitoring at the same Madrid facility have returned negative hantavirus test results.

    Passengers holding Spanish nationality who were aboard the MV Hondius were among the first group to disembark the vessel at the Canary Island port of Tenerife on Sunday. After disembarkation, they were immediately transferred to a military hospital to undergo mandatory isolation and comprehensive public health evaluations.

    The outbreak on the expedition cruise ship has sparked international public health concern, after the World Health Organization (WHO) verified the full 11-case count linked to the vessel. Nine of the confirmed infections have been identified as the Andes hantavirus strain, a particularly pathogenic variant of the virus. All documented cases to date are either passengers or crew members who were aboard the MV Hondius.

    In a public health update, WHO officials noted that as of the latest assessment, there is no evidence indicating that the outbreak is spreading beyond individuals who had direct exposure to the cruise ship. Public health teams across Spain and international health bodies continue to monitor all monitored individuals closely to prevent any potential secondary spread of the virus.